Search

Your search keyword '"Cooper, Nichola"' showing total 391 results

Search Constraints

Start Over You searched for: Author "Cooper, Nichola" Remove constraint Author: "Cooper, Nichola" Language english Remove constraint Language: english
391 results on '"Cooper, Nichola"'

Search Results

3. Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework

4. The role of CD8+ T-cell clones in immune thrombocytopenia

8. Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19

9. Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

11. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells

17. Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.

18. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial

20. Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders

21. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

22. The role of Protein Kinase Cα in the skin and cutaneous wound healing

24. Human retinoic acid–regulated CD161+ regulatory T cells support wound repair in intestinal mucosa

27. Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura

29. Safety and efficacy of SARS‐CoV‐2 vaccination in patients with immune thrombocytopenia: A two‐centre review.

31. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib.

32. European Delphi panel to build consensus on tapering and discontinuing thrombopoietin receptor agonists in immune thrombocytopenia.

33. Could machine learning revolutionize how we treat immune thrombocytopenia?

35. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

36. A HaemSTAR-led, UK-wide 'flash-mob’ audit of ­intravenous immunoglobulin use in immune ­thrombocytopenia

38. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements

43. Retrospective, Observational, Multicenter Study Assessing the Thrombopoietin Receptor Agonist (TPO-RA) Romiplostim and Other Treatments for Patients with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in the United Kingdom (UK)

44. Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling

45. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

46. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

48. The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trial.

49. Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Catalog

Books, media, physical & digital resources